Consulting AgreementConsulting Agreement • September 5th, 2024 • Oruka Therapeutics, Inc. • In vitro & in vivo diagnostic substances • California
This Consulting Agreement (the “Agreement”) is effective as August 30, 2024 (the “Effective Date”), by and between Oruka Therapeutics, Inc., a Delaware corporation, with a principal place of business at 855 Oak Grove Avenue, Suite 100, Menlo Park, California 94025 (“Oruka”), and C. Jeff Dekker, an individual with a mailing address of [***] (“Consultant”). Oruka and the Consultant shall each be referred to herein individually as “Party” or collectively, as “Parties” to this Agreement.
Employee Warrant AgreementEmployee Warrant Agreement • September 5th, 2024 • Oruka Therapeutics, Inc. • In vitro & in vivo diagnostic substances • Delaware
THIS EMPLOYEE WARRANT AGREEMENT (the “Agreement”), dated as of the purchase date set forth above (the “Purchase Date”), is made by and between Oruka Therapeutics, Inc., a Delaware corporation (the “Company”), and the individual set forth above, who is an employee of or service provider to the Company (the “Employee Warrant Purchaser”).
